Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
about
Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical informationLead-like, drug-like or "Pub-like": how different are they?Experimental and computational studies of fatty acid distribution networks.A NON-LINEAR STRUCTURE-PROPERTY MODEL FOR OCTANOL-WATER PARTITION COEFFICIENTSynthesis and photochemical properties of PEGylated coumarin-caged ceramides for cell studies.On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.Synthesis and characterization of mono-, di-, and tri-poly(ethylene glycol) chlorin e6 conjugates for the photokilling of human ovarian cancer cellsPerfluoroalkyl sulfonic and carboxylic acids: a critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods.A renaissance of neural networks in drug discovery.Metabolic Complementation in Bacterial Communities: Necessary Conditions and Optimality.Membrane Affinity of Platensimycin and Its Dialkylamine Analogs.Structure-activity relationships of 11 new congeners of the SMTP plasminogen modulator.Automated potentiometric titrations in KCl/water-saturated octanol: method for quantifying factors influencing ion-pair partitioning.Cassia obtusifolia MetE as a cytosolic target for potassium isolespedezate, a leaf-opening factor of Cassia plants: target exploration by a compact molecular-probe strategy.Exploring the Multiligand Binding Specificity of Saposin B Reveals Two Binding Sites.Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods.Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking.Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients?Prediction of Log P with Property-Based MethodsThe Good, the Bad and the Ugly of Distribution Coefficients: Current Status, Views and OutlookIn silicoevaluation of logD7.4and comparison with other prediction methodsComputational Absorption Prediction
P2860
Q28530221-3EC39EE4-2321-4EE4-828D-09E9E80C2C5AQ33276455-33BC720C-EC85-4EE5-8A9E-AA43C8836070Q35748105-8ED8A50A-C8EA-4DB7-9FF6-0A564D996EEEQ36419612-9894D5AA-DFFE-4CC6-9E23-FA671F960917Q36479761-C1CA6A34-ECE3-4DE5-B3CA-60D4A15A7509Q37213210-A2D31204-5B1A-48A4-BD3E-97EAEAAC08A3Q37274393-C145AEAF-1BBE-496D-AC70-5195749288FDQ37619332-A101AC87-0946-4210-9118-B1E1ABD638ADQ38854003-BD17389D-A90F-4532-84F1-3D8F49939E88Q41361551-31CFBEF9-C247-49CF-AA3A-7EE32106E7F7Q42129187-8B97BEF9-0C02-443D-BEEE-B2669B22B406Q42907166-6E2E12DC-EE45-4033-A3CA-AF178F81891BQ43151257-EDB97411-F9DC-4F3C-9099-34DA51CE43DCQ45356847-EF42499F-74F4-48A9-9BE3-E213EEE1DD9DQ46418232-BB56980E-9A85-4C46-A0AC-CB994AC512E6Q49636957-FA34153B-0766-455A-99E5-90E7B904AA03Q49860498-8742E317-FDAF-454E-947A-5CE1D9048101Q50553513-E9C2C4EC-2FF7-4BDB-89AF-D4159064945CQ56916453-BEBD572C-89CC-46CF-8CB6-917A74025B4BQ56916461-E016521F-0CCE-4490-9A40-32275E2B4D28Q59112826-1AB40194-1F80-4736-AA18-89A756B6E70AQ59188905-262C929F-5A4A-4D5E-917F-B2F774D05BB1
P2860
Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@ast
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@en
type
label
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@ast
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@en
prefLabel
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@ast
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@en
P356
P1476
Application of ALOGPS 2.1 to p ...... Pfizer proprietary compounds.
@en
P2093
Gennadiy I Poda
P304
P356
10.1021/JM049509L
P407
P577
2004-11-01T00:00:00Z